Related Articles
Induction of protective immunity against MHC class I-deficient, HPV16-associated tumours with peptide and dendritic cell-based vaccines
Immunization with MHC class I-negative but not -positive HPV16-associated tumour cells inhibits growth of MHC class I-negative tumours
Fungal mannosylation enhances human papillomavirus 16 E7 therapeutic immunity against TC-1 tumors
Vaccination of full-length HPV16 E6 or E7 protein inhibits the growth of HPV16 associated tumors
Establishment and characterization of a mouse tumor cell line with irreversible downregulation of MHC class I molecules